Related Experiment Video
Updated: May 6, 2026

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
[Pathophysiology of NAsh/NAFLD associated with high levels of serum triglycerides]
Abstract:
The patients with nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepa-titis(NASH) often have dyslipidemia along with other features of metabolic syndrome such as obesity, diabetes mellitus, and hypertension. The dyslipidemia in NAFLD is characterized by increased serum triglycerides, increased small dense low-density lipoprotein, and low high-density lipoprotein cholesterol. The pathogenesis of dyslipidemia in NAFLD is not well understood, but it is likely related to hepatic overproduction of the very low-density lipoprotein 1 and decreasing clearance of lipoproteins from the circulation. Recently it is showed that free fatty acids induce hepatocyte lipoapoptosis in vitro. In this manuscript we discuss about "hypertriglyceridemia and NASH/NAFLD".
More Related Videos
Related Concept Videos
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Nephrotic Syndrome I : Introduction
Cirrhosis II: Pathophysiology
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Cirrhosis I: Introduction

